Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 1,474,467 |
|
|||||
| News | - | ||||||
| Day High | 12.04 | Low High |
|||||
| Day Low | 11.07 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Stoke Therapeutics Inc | STOK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.40 | 3.55% | 11.66 | 19:05:05 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 11.18 | 11.07 | 12.04 | 11.66 | 11.26 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,581 | 1,474,467 | $ 11.61 | $ 17,119,578 | - | 3.35 - 16.3999 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:26:35 | 26 | $ 11.1888 | USD |
Stoke Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 520.66M | 44.65M | - | 8.78M | -104.7M | -2.34 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Stoke Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical STOK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.51 | 12.97 | 10.90 | 11.59 | 1,027,724 | -0.85 | -6.79% |
| 1 Month | 11.20 | 16.3999 | 10.35 | 13.32 | 2,164,178 | 0.46 | 4.11% |
| 3 Months | 4.86 | 16.3999 | 4.09 | 11.36 | 1,255,305 | 6.80 | 139.92% |
| 6 Months | 3.65 | 16.3999 | 3.35 | 10.31 | 692,203 | 8.01 | 219.45% |
| 1 Year | 8.58 | 16.3999 | 3.35 | 9.48 | 509,997 | 3.08 | 35.90% |
| 3 Years | 32.21 | 41.60 | 3.35 | 13.29 | 339,005 | -20.55 | -63.80% |
| 5 Years | 27.21 | 71.58 | 3.35 | 17.76 | 272,000 | -15.55 | -57.15% |
Stoke Therapeutics Description
| Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. |
